Align Technology (ALGN)
| Company | Ticker | Sector | Industry | Quality | PAR |
|---|---|---|---|---|
| Align Technology | ALGN | Healthcare | Medical Devices | 96 | 16.4% |
| Current Price (08/12) | $289.00 | |||
| CAPS Rating (Rate this stock on CAPS) |  |
|||
| Expected Income Statement | ||||
| Current Sales | 4,031.0 | |||
| Sales Growth Forecast | 22.8% | |||
| Net Profit Margin | 18.3% | |||
| Projected Shares Outstanding | 79.75 | |||
| EPS - Five year Forecast | $25.79 | |||
| Average P/E Ratio | 24.0 | |||
| Projected Average Price | $618.86 | |||
| Price Appreciation (Annualized) | 16.4% | |||
| Annual Dividend Yield | 0.0% | |||
| Projected Annual Return | 16.4% | |||
| Quality | ||||
| Financial Strength | 61 | 15.2 | ||
| EPS Stability | 92 | 23.0 | ||
| Industry Sales Growth Rate | 11.5% | 24.7 | ||
| Industry Net Profit Margin | 15.5% | 14.8 | ||
| Calculated Quality Rating | 78.0 | |||
| Fool CAPS | ||||
Total Players
506
Outperforms
52
Underperforms
All-Stars (146)
135
Outperforms (92%)
11
Underperforms
|
||||
| Fundamental Data Updated: 06/24/2022 | ||||